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Abstract
AIM
To determine the laboratory and radiologic parameters, 
including the platelet count (PC)-to-spleen diameter 
(SD) ratio as a non-invasive marker that may predict 
the presence of esophageal varices (EV) in children 
with cirrhosis.
METHODS
Eighty-nine patients with cirrhosis, but without a history 
of variceal bleeding were prospectively included. The 
children were grouped into 6-12 and 12-18 years of 
age groups. These groups were also divided into 2 sub-
groups (presence and absence of EV). All of the patients 
underwent a complete biochemical and radiologic evalua-
tion. The PC (n/mm3)-to-SD (mm) ratio was calculated 
for each patient. 
RESULTS
Sixty-nine of 98 (70.4%) patients had EV. The presence 
of ascites in all age groups was significantly associated 
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with the presence of EV. There were no differences in 
serum albumin levels, PC, SD and the PC-to-SD ratio 
between the presence and absence of EV groups in 
both age groups (P  > 0.05). 
CONCLUSION
Laboratory and radiologic parameters, including the 
PC-to-SD ratio as a non-invasive marker (except for the 
presence of ascites), was inappropriate for detecting 
EV in children with cirrhosis.  
Key words: Esophageal varices; Variceal bleeding; 
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Core tip: Laboratory and radiologic parameters, in-
cluding the platelet count (PC)-to-spleen diameter (SD) 
ratio were investigated in children with cirrhosis as a 
non-invasive marker that may predict the presence of 
esophageal varices (EV). This study is the first study 
to assess the PC-to-SD ratio in children with cirrhosis 
for detecting EV according to age groups This study 
demonstrated that the parameters, other than the 
presence of ascites, were inappropriate for detecting EV 
in children with cirrhosis.  
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INTRODUCTION
Esophageal variceal bleeding is among the most serious 
consequences of chronic liver disease[1]. Approximately 
two-thirds of children with cirrhosis have esophageal 
varices (EV), and the mortality associated with a 
variceal bleeding episode is 20%-35%[1-4]. Prevention 
of bleeding from a ruptured EV has become one of the 
main goals in the follow-up of these patients. Although 
a consensus has been reached for adults, there is no 
formal recommendation for endoscopic screening in 
children with cirrhosis[5]. 
Esophagogastroduodenoscopy (EGD) is the present 
reference standard diagnostic test for EV. Nevertheless, 
only 50%-70% of cirrhotic patients have varices on 
the first EGD and < 30% have large varices and/or the 
red wale sign (high-risk EV for bleeding) in adults and 
children[6-8]. Because of the relatively low prevalence 
of varices that require primary prophylaxis, the cost, 
inconvenience, and morbidity associated with endoscopic 
surveillance may not be justified for all patients with 
cirrhosis. To reduce the increasing burden on endoscopy 
units and prevent unnecessary harm to patients, researchers 
have attempted to identify parameters for non-invasive 
prediction of EV[9]. Several reports have identified non-
invasive variables that may predict the presence of EV in 
childhood and have shown predictive factors for bleeding 
risk, such as hypoalbuminemia, the Child-Pugh score, an 
increased spleen diameter (SD), a low platelet count (PC), 
the PC-to-SD ratio, the clinical prediction rule, and the 
aspartate aminotransferase-to-platelet ratio index[6,7,10]. 
For this purpose, the PC-to-SD ratio was investigated 
to predict the presence of EV in adult patients with 
cirrhosis[11-14]. Chawla et al[15] concluded that the PC-to-
SD ratio is elegant, simple and inexpensive, and it may 
become a helpful tool to limit the number of endoscopies 
for primary prophylaxis in adult patients with portal hyper-
tension. Therefore, we conducted this study to investigate 
laboratory and radiologic parameters, including the PC-
to-SD ratio, as predictors of EV in children with cirrhosis.
MATERIALS AND METHODS
All children (6-18 years of age) who had been diagnosed 
with cirrhosis in the outpatient clinics of the Paediatric 
Gastroenterology Hepatology and Nutrition at Baskent 
University, Ankara, Turkey, were included in this pro-
spective study. The diagnosis of cirrhosis was made 
based on laboratory, radiologic, and physical examination 
findings or by liver histology in the absence of clear 
clinical signs of liver cirrhosis. Demographic characteristics 
(age, gender and underlying disease), blood chemistry 
evaluations, international normalized ratio, and Child-
Pugh scores were recorded for each patient.
Patients with a clinical history of upper digestive hemo-
rrhage, band ligation, sclerosing therapy, transjugular 
intrahepatic portosystemic stent shunt, surgery for portal 
hypertension, hepatic encephalopathy, and use of beta-
blockers or other vasoactive drugs were excluded from 
the study. 
The children were further grouped into 6-12 and 
12-18 year age groups. These groups  were divided 
into two sub-groups (EV-present and -absent) based 
on the EGD. The EGD was performed by the same 
paediatric endoscopists in our endoscopy unit using a 
video endoscope (Olympus GIF-XP 240; Tokyo, Japan 
or Fujinon EG 590W videoendoscopy; Tokyo, Japan). EV 
were classified according to the Baveno IV criteria[16,17] 
and American Association for the Study of Liver Diseases 
practice guidelines[18] as no, small, and large varices. EV 
were also classified according to the bleeding risk as high 
risk and non-high risk using varices diameters and red 
sign parameters.
The spleen bipolar diameter and presence of ascites 
were evaluated by ultrasonography (Siemens Sonoline 
Antares 4.1 MHz or 9.4 MHz probe; Siemens Medical 
Solutions United States, Inc., Issaquah, WA, United 
States) by the same radiologist.
The study design was approved by the Ethics Com-
mittee of our hospital (Study No. KA11/11252). Before 
enrollment, written informed consent was obtained from 
the primary caretaker of each patient.
We used SPSS software (version 16.0; SPSS, Inc., 
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Chicago, IL, United States) for statistical analysis. Data 
are expressed as the mean and standard deviation and 
proportions. For comparison of categorical variables, 
Fisher’s exact test or a χ 2 test was used. Differences 
between numeric variables were tested with a Mann-
Whitney U-test. Values of P < 0.05 were considered to 
indicate statistically significant differences.  
RESULTS
Ninety-eight children with cirrhosis were included in this 
study. The ages of the children ranged from 6-18 years 
(median age, 12.16 ± 2.70 years). Forty-six children 
were females (46.9%) and 52 were males (53.1%). 
The etiology of cirrhosis was cryptogenic cirrhosis (n 
= 40), Wilson’s disease (n = 35), progressive familial 
intrahepatic cholestasis (2), sclerosing cholangitis (n = 
4), Budd-Chiari syndrome (n = 4), tyrosinemia (n = 3), 
glycogen storage disease (n = 3), autoimmune hepatitis 
(n = 2), hepatitis B infection (n = 2), Allagille syndrome 
(n = 2), and alfa1-antitrypsin deficiency (n = 1). Sixty-
one patients were Child-Pugh class A, 29 were class B, 
and 8 were class C.
In this study, 69 children (70.4%) were shown to 
have EV based on the first EGD and 29 children (29.6%) 
were shown not to have EV.  
Fifty-five of the 69 patients had small EV (79.7%) 
and 14 patients (20.3%) had large EV. There were 11 
children (15.9%) with red wale signs (seven children 
had large EV and four children had small EV). Therefore, 
18 of the 69 patients with EV (26.1%) had high-risk EV 
for bleeding according to the presence of large varices 
and/or red sign (six patients in the 6-12 year age group, 
and 12 patients in the 12-18 year age group).
There were no differences in age and gender between 
the EV-present and -absent sub groups in both age 
groups (P > 0.05). In the two age groups, a higher 
percentage of ascites was observed among the EV-
present group than the EV-absent group (Tables 1 and 2). 
We did not find a statistically significant difference in 
the PC-to-SD ratio between patients with large and 
small varices (636.9 ± 256.5 and 894.1 ± 844.4, re-
spectively; P = 0.89).
We did not find a significant difference for serum 
albumin, PC, SD and the PC-to-SD ratio between the 
EV-present and -absent varices sub-groups in both age 
groups (P > 0.05; Tables 1 and 2). 
DISCUSSION
Despite advances in diagnosis and treatment, bleeding 
from EV is one of the major causes of morbidity and 
mortality among patients with cirrhosis. Hence, pre-
venting the first episode of variceal bleeding may reduce 
mortality and morbidity.
In this prospective study involving children 6-18 years 
of age with cirrhosis, we found that only the presence of 
ascites is associated with the presence of EV. There have 
been several studies identifying non-invasive variables 
that may predict the presence of EV in children[6,7,10]. 
The first study, in which the predictive risk factors were 
evaluated by Fagundes et al[6] in a pediatric group [median 
age at the time of first EGD was 6 years (age range, 
0.7-17.6 years)], showed that children with cirrhosis 
and splenomegaly were nearly 15-fold more likely 
to have EV compared with children with cirrhosis but 
without splenomegaly. Fagundes et al[6] concluded that 
hypoalbuminemia, splenomegaly, and a PC < 130000/
mm3 were predictors for the presence of EV, spleen 
size was not measured by ultrasonography. The second 
study, conducted by Gana et al[7], derived a non-invasive 
clinical prediction rule capable of identifying children with 
EV. In this study, 17 of 51 children (< 18 years of age) 
with liver disease or portal vein thromboses were shown 
Patient with 
varices (n  = 29)
Control 
(n  = 13)
P  value
Mean age (yr)   9.7 ± 2.0 10.0 ± 1.9 0.595
Gender (% female) 45 38.5 0.384
INR   1.5 ± 0.5   1.4 ± 0.5 0.860
ALT (IU/L)   57.3 ± 50.8   44.3 ± 29.3 0.210
AST (IU/L)   79.1 ± 71.5   53.1 ± 32.9 0.241
Total bilirubin (mg/dL)   3.5 ± 6.0   2.5 ± 4.7 0.618
Albumin (mg/dL)   3.9 ± 0.6   4.2 ± 0.6 0.231
Ultrasonographic 
ascites (%)
27.5% 0% 0.037
Spleen diameter (mm) 167.3 ± 39.1 151.3 ± 32.4 0.206
Platelet count 
(thousand/mm3)
129000 ± 53519 153000 ± 97798 0.312
Platelet count/spleen 
diameter
  976.6 ± 793.5 1062.4 ± 718.0 0.741
Child-Pugh score   6.3 ± 1.5   5.7 ± 1.4 0.193
Table 1  Laboratory and ultrasonographic data in the age 
group of 6-12 years
INR: International normalized ratio; ALT: Alanine transaminase; AST: 
Aspartate transaminase.
Patient with  
varices (n  = 40)
Control 
(n  = 16)
P  value
Mean age (yr) 14.2 ± 1.7 13.5 ± 1.2 0.161
Gender (% female) 48 56 0.591
INR   1.3 ± 0.3   1.4 ± 0.6 0.347
ALT (IU/L)   86.5 ± 76.1   60.5 ± 67.2 0.250
AST (IU/L)   115.2 ± 124.2   105.5 ± 231.8 0.842
Total bilirubin (mg/dL)     5.0 ± 10.4     5.3 ± 12.5 0.931
Albumin (mg/dL)   3.8 ± 0.7   3.9 ± 0.7 0.757
Ultrasonographic 
ascites (%)
35% 6% 0.028
Spleen diameter (mm) 181.4 ± 37.2 150.3 ± 34.2 0.389
Platelet count 
(thousand/mm3)
103000 ± 55867 115000 ± 65472 0.499
Platelet count/spleen 
diameter
  733.9 ± 737.4 830.78 ± 553.5 0.637
Child-Pugh score   6.9 ± 1.9   6.2 ± 1.8 0.214
Table 2  Laboratory and ultrasonographic data in the age 
group of 12-18 years
INR: International normalized ratio; ALT: Alanine transaminase; AST: 
Aspartate transaminase.
Sezer OB et al . Platelet count/spleen diameter ratio esophageal varices
1469 November 28, 2016|Volume 8|Issue 33|WJH|www.wjgnet.com
to have EV, and hypoalbuminemia was shown to be an 
independent variable for the presence of EV. In the same 
study[7], a higher percentage of ascites, increased spleen 
length, and lower PC (cut-off value = 115000/mm3) 
were reported among children with EV. Further, the PC-
to-spleen length-for age Z score ratio was significantly 
lower among the EV-present group[7]. 
Fagundes et al[6] and Gana et al[7] reported lower 
albumin levels among children with EV. Our results were 
not in agreement with the findings of these two studies. 
A possible explanation may be the difference in etiologic 
factors in our patients.
A recent study involving 103 patients with a diag-
nosis of chronic liver disease or extrahepatic portal 
vein obstruction (mean age, 8.9 ± 4.7 years) showed 
a significantly higher spleen length and lower PC (cut-
off value = 115000/mm3) among children with EV than 
children without EV[10]. In the same study, it was reported 
that a PC-to-spleen size (cm) ratio < 1.0 discriminated 
between patients with and without EV, despite a lack of 
statistical significance based on logistic regression. The 
authors suggested that the lack of statistical significance 
was explained by the age and gender differences in 
spleen size.
Based on the findings of these three studies[6,7,10], 
low PC and increased spleen length are logical para-
meters by which to determine EV in children with 
cirrhosis. In addition, Gana et al[7] and Adami et al[10] 
reported that PC (cut-off value = 115000/mm3) was the 
best predictor of EV. 
In the current study, we did not find a significant 
difference for PC, SD and the PC-to-SD ratio between the 
EV-present and -absent sub-groups in both age groups. 
A possible explanation is the heterogeneity of patients 
studied. Another explanation is the lack of children 
with portal vein thromboses in the current study. The 
three studies investigating risk factors for EV included 
children with cirrhosis and portal vein tromboses[6,7,10]. 
It is well-known that portal vein thrombosis is a risk 
factor for splenomegaly and thrombocytopenia. The PC 
loses discriminatory power because of multi-causality 
(such as autoimmune events, myelotoxic effects of 
viruses, or reduced synthesis of thrombopoietin) as a con-
sequence of progressive liver dysfunction; however, in 
children with portal vein thromboses, thrombocytopenia 
is directly related to portal hypertension, as well as the 
development of varices[19]. 
One of the most important limitations of our study 
was the small number of patients; however, this study 
was the first study to assess the PC-to-SD ratio in 
children in two age groups with cirrhosis as a means to 
detect EV. We consider the PC, SD and PC-to-SD ratio 
to lack suitability as non-invasive markers for detecting 
EV in children with cirrhosis. Further studies on this 
subject with larger sample sizes are required to assess 
the importance of the PC, SD and PC-to-SD ratio in 
cirrhotic children with or without portal vein thrombosis.
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